Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TAGCyx Biotechnologies

TAGCyx Biotechnologies
2007 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series B LATEST DEAL TYPE
$4.66M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of a drug discovery platform designed to identify and develop novel nucleic acid-based drugs. The company's platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Tokyo University Komaba Open Laboratory #403
  • 4-6-1 Komaba, Meguro-ku
  • Tokyo, Tokyo 153-0041
  • Japan
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TAGCyx Biotechnologies’s full profile, request a free trial.

TAGCyx Biotechnologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 27-Apr-2018 $4.66M 00.00 Completed Generating Revenue
1. Early Stage VC (Series A) 31-Aug-2016 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

TAGCyx Biotechnologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Mizuho Capital Partners Venture Capital Minority 000 0000 000000 0
UTokyo Innovation Platform Venture Capital Minority 000 0000 000000 0
Nissay Capital Venture Capital Minority 000 0000 000000 0
SMBC Venture Capital Venture Capital Minority 000 0000 000000 0
The University of Tokyo Edge Capital Venture Capital Minority 000 0000 000000 0

TAGCyx Biotechnologies Executive Team (1)

Name Title Board
Seat
Contact
Info
Chizuko Koseki Ph.D President & Chief Executive Officer

TAGCyx Biotechnologies Board Members (4)

Name Representing Role Since Contact
Info
Akinori Mochizuki Ph.D Self Board Member 000 0000
Maiko Katadae Ph.D The University of Tokyo Edge Capital Board Member 000 0000
Takahiro Kono Self Board Member 000 0000
Yoshiyuki Yamakawa Self Board Member 000 0000